| # | Title | Journal | Year | Citations |
|---|
| 1 | Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis | Pediatric Rheumatology | 2016 | 160 |
| 2 | Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO) | Pediatric Rheumatology | 2013 | 155 |
| 3 | Blau Syndrome, the prototypic auto-inflammatory granulomatous disease | Pediatric Rheumatology | 2014 | 145 |
| 4 | Childhood sarcoidosis: A rare but fascinating disorder | Pediatric Rheumatology | 2008 | 143 |
| 5 | Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO) | Pediatric Rheumatology | 2009 | 142 |
| 6 | Clinical outcome measures in juvenile idiopathic arthritis | Pediatric Rheumatology | 2016 | 133 |
| 7 | Treatment of juvenile idiopathic arthritis: a revolution in care | Pediatric Rheumatology | 2014 | 125 |
| 8 | Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome | Pediatric Rheumatology | 2017 | 123 |
| 9 | A comprehensive review of the genetics of juvenile idiopathic arthritis | Pediatric Rheumatology | 2008 | 119 |
| 10 | IgG4-related disease: a systematic review of this unrecognized disease in pediatrics | Pediatric Rheumatology | 2016 | 114 |
| 11 | Behçet’s disease in children, an overview | Pediatric Rheumatology | 2016 | 111 |
| 12 | Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition | Pediatric Rheumatology | 2019 | 110 |
| 13 | Farber disease: clinical presentation, pathogenesis and a new approach to treatment | Pediatric Rheumatology | 2007 | 109 |
| 14 | Juvenile idiopathic arthritis-associated uveitis | Pediatric Rheumatology | 2016 | 107 |
| 15 | Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases | Pediatric Rheumatology | 2009 | 105 |
| 16 | Type I interferonopathies in pediatric rheumatology | Pediatric Rheumatology | 2016 | 104 |
| 17 | Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity | Pediatric Rheumatology | 2015 | 100 |
| 18 | The temporomandibular joint in juvenile idiopathic arthritis: frequently used and frequently arthritic | Pediatric Rheumatology | 2009 | 99 |
| 19 | Monogenic polyarteritis: the lesson of ADA2 deficiency | Pediatric Rheumatology | 2016 | 96 |
| 20 | High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report | Pediatric Rheumatology | 2014 | 90 |
| 21 | Mutations in CECR1 associated with a neutrophil signature in peripheral blood | Pediatric Rheumatology | 2014 | 88 |
| 22 | High rates of unsuccessful transfer to adult care among young adults with juvenile idiopathic arthritis | Pediatric Rheumatology | 2010 | 87 |
| 23 | The iPeer2Peer Program: a pilot randomized controlled trial in adolescents with Juvenile Idiopathic Arthritis | Pediatric Rheumatology | 2016 | 87 |
| 24 | Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis | Pediatric Rheumatology | 2013 | 85 |
| 25 | Clinical features of childhood granulomatosis with polyangiitis (wegener’s granulomatosis) | Pediatric Rheumatology | 2014 | 85 |
| 26 | Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches | Pediatric Rheumatology | 2021 | 85 |
| 27 | The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months | Pediatric Rheumatology | 2017 | 80 |
| 28 | Chronic nonbacterial osteomyelitis in children: a retrospective multicenter study | Pediatric Rheumatology | 2015 | 79 |
| 29 | Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey | Pediatric Rheumatology | 2021 | 78 |
| 30 | Burden of childhood-onset arthritis | Pediatric Rheumatology | 2010 | 76 |
| 31 | Pediatric complex regional pain syndrome: a review | Pediatric Rheumatology | 2016 | 76 |
| 32 | Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting | Pediatric Rheumatology | 2018 | 76 |
| 33 | Ultrasonography and color Doppler in juvenile idiopathic arthritis: diagnosis and follow-up of ultrasound-guided steroid injection in the ankle region. A descriptive interventional study | Pediatric Rheumatology | 2011 | 75 |
| 34 | Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome | Pediatric Rheumatology | 2019 | 74 |
| 35 | Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis | Pediatric Rheumatology | 2015 | 72 |
| 36 | Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany | Pediatric Rheumatology | 2018 | 72 |
| 37 | Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what? | Pediatric Rheumatology | 2018 | 72 |
| 38 | pGALS – paediatric Gait Arms Legs and Spine: a simple examination of the musculoskeletal system | Pediatric Rheumatology | 2013 | 71 |
| 39 | Deregulation of the IL-1β axis in chronic recurrent multifocal osteomyelitis | Pediatric Rheumatology | 2014 | 71 |
| 40 | Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study | Pediatric Rheumatology | 2012 | 70 |
| 41 | PFAPA syndrome: a review on treatment and outcome | Pediatric Rheumatology | 2016 | 70 |
| 42 | Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years | Pediatric Rheumatology | 2013 | 69 |
| 43 | Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis | Pediatric Rheumatology | 2015 | 69 |
| 44 | Maximal mouth opening capacity: percentiles for healthy children 4–17 years of age | Pediatric Rheumatology | 2013 | 68 |
| 45 | Intestinal Behçet and Crohn’s disease: two sides of the same coin | Pediatric Rheumatology | 2017 | 68 |
| 46 | Muscle strength, physical fitness and well-being in children and adolescents with juvenile idiopathic arthritis and the effect of an exercise programme: a randomized controlled trial | Pediatric Rheumatology | 2013 | 67 |
| 47 | Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease | Pediatric Rheumatology | 2017 | 65 |
| 48 | Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study | Pediatric Rheumatology | 2017 | 64 |
| 49 | The differential diagnosis of children with joint hypermobility: a review of the literature | Pediatric Rheumatology | 2009 | 63 |
| 50 | The challenges of transferring chronic illness patients to adult care: reflections from pediatric and adult rheumatology at a US academic center | Pediatric Rheumatology | 2009 | 62 |
